TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: GMT of neutralizing antibodies against live SARS-CoV-2 virus on day 28 after the second dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: ATX-LPA inflammatory response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: DeadSpace
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Ventilation-perfusion matching (VQmatch)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Global inhomogeneity index (VQmatch-GI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Thickness of the cornea before and after the stress test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The rate of corneal recovery after the stress test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to full recovery from swelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IPN semi-quantitative grading
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of patients with adverse events leading to treatment discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Security of MSC therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Kappa coefficient of normal and abnormal results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Intraoperative iris hernia occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Incidence of unfavorable functional outcome
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Vascular Imaging Modality Effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Sensitivity and specificity of the GIFT device
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of (S)AEs by type and grade
Endpoint domain: Adverse events/effects
Primary endpoint: Improved patient function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: All-cause healthcare resource utilization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: All-cause healthcare costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Melanoma-specific healthcare resource utilization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Melanoma-specific healthcare costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of patients with ETI in expected reference range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Clinical Laboratory Abnormalities (Chemistry, Hematology, Urinalysis)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in estimated pulmonary artery pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in gut microbial profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Changes in oral microbial profile (saliva samples)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in oral microbial profile (subgingival plaque samples)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Awakening time from anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total recovery of radioactivity in urine and feces as percentage of total radioactive dose administered
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Effectiveness of high calorie formula
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Eczema Area and Severity Index (EASI-75)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Investigator's Global Assessment (IGA) score of 0/1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Healthy Life Style Behavior Scale II
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Success rate of bilateral adrenal venous sampling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Behaviour Rating Inventory Of Executive Function-Adult
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Perceived Deficit Questionnaire 5
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: impact of cryotherapy on obstructive sleep apnea syndrome
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: side effects of cryotherapy
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage time spent in glucose target
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Evidence of Luteal Activity (ELA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Determination of pulsatile LH secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Uterine bleeding pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intervention adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ACTaide mobile app acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of unnecessary antibiotics
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: occurrence of cytokine release syndrome
Endpoint domain: Adverse events/effects
Primary endpoint: Number of successful neonate deliveries with the Yaari Extractor device
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time interval (minutes) from the diagnosis of the shoulder dystocia until the neonate's delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal and neonatal adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Subjects with cardiovascular adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Release of gut hormones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cost-effectiveness of PVI relative to usual care
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Analytical sensitivity of the multiparameter panel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Caregiver Mastery Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in proteinuria (natural log UPCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Prevalence of Axial- and Peripheral Spondyloarthritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Axial- and Peripheral Spondyloarthritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chronic pelvic pain severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional hemodynamic assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with CS-1103-related adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Time in target blood glucose range per CGM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Asthma exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change from baseline vascular function at 2 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change from baseline muscle strength at 2 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change from baseline grip strength at 2 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Occurrence of TEAEs leading to permanent withdrawal of Investigational Medicinal Product (IMP)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Effectiveness of education modules
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Time to recovery of circulating neutrophils
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Time to recovery of platelets
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Induction of CD4+ TRM cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Efficacy (PPV and FPR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and Percentage of Participants with a Treatment Emergent Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Number and Percentage of Participants with Potentially Clinically Significant Postbaseline Changes in Clinical Laboratory Evaluations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and Percentage of Participants with Potentially Clinically Significant Postbaseline Changes in Vital Signs and Body Weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and Percentage of Participants with Potentially Significant Postbaseline Changes in Electrocardiogram Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Asthma Impairment and Risk Questionnaire (AIRQ®) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety of COVAC-1 booster vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Universal Mental Health Literacy Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Depression Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in PROMIS Anxiety Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Safety and adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Time in Centre (TIC) on Treatment Day
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in maximum glucagon-induced reduction in total plasma amino acid concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of participants with clinical improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Flanker Task performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Rule Switch Task performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Cancellation Task performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in N-Back Task performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Letter-Number Task performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Corsi Task performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Human papillomavirus (HPV) clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Changes in vaginal bacterial quantity (population) that colonize, called Community State Type (CST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Assessment of lumbar flexion range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Craving Domains
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Acceptability of Craving Assessments
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Deficits in Craving Assessments
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Suturing time to close the vaginal cuff
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Safety of Magneto PE Kit
Endpoint domain: Adverse events/effects
Primary endpoint: Annual Rate of Major Bacterial Infections
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with Tumor Lysis Syndrome (TLS)
Endpoint domain: Adverse events/effects
Primary endpoint: Dialysis sessions success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anesthesia time excluding operation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: 99mTc-ABH2 uptake value in tumor lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cytokine level production of IL-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cytokine level production of IL-17
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Patient-Oriented Composite Outcome
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Measurement of pelvic floor muscle activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Evaluation of pulmonary function-FVC%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Evaluation of respiratory muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Non-invasive Tear Film Break-up Time (NiBUT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body Composition Profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Periodontal healing index (PQI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from Documented AF Without Antiarrhythmic Drugs at 12 Months Post-Ablation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of Composite Procedure-Related Serious Adverse Events at 3 Months Post-Ablation
Endpoint domain: Adverse events/effects
Primary endpoint: Usability based on user survey
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total number (%) of AEs and SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Parasuicidal behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Generalized Anxiety Disorder (GAD-7)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dissociative Experiences Scale - II (DES-II)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in incidence of falls associated with urinary toileting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in level of user independence
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Levels of user confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Temperature of acupoints
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain threshold of acupoints
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: very long-term efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duke activity status index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Diagnostic accuracy of Quantitative Flow Ratio (QFR) against Fractional Flow Reserve (FFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Average sample delivery time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: % of accepted sample
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of sample suitable for RNA extraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of alarms per patient per day
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: length of time patients have potentially dangerous heart rate, blood pressure or oxygen saturation values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Ability to perform different activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Psycho-social assessment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Life's Quality assessment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Autism Treatment Evaluation Checklist
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Vineland Adaptive Behavior Scales - Third Edition, Chinese Version (VABS-3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comparison of RESP Biosensor System output to physician breath sound interpretation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee medial compartment distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Tibiofemoral angle measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Proportion of patients adhering to the study protocol
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of patients crossing over to VV ECMO
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of patients recruited for the study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of aspiration pneumonia
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in electromyography of eccentric acting muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in kinetics during weight acceptance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in kinematics during weight acceptance: hip range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Striatal Dopamine Release
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurotransmitter outcomes
Primary endpoint: Rate of successful same day chest tube removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: EuroQol 5 Dimension 5 Level (EQ5D5L) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean Morphine Equivalents (MME) Post-Operative Day 1 (POD1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-year Disease-Free Survival Percentage
Endpoint domain: Mortality/survival
Primary endpoint: Cervical Posture Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper limb grip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quick DASH to measure upper limb disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: IMACS-TIS (TIS40) Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency and severity of abnormal adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency and severity of abnormal ECOG PS
Endpoint domain: Adverse events/effects
Primary endpoint: Pre-exposure prophylaxis (PrEP) Contemplation Ladder total score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in DSMES Referrals
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: AUC area under the plasma concentration-time curve from time 0 to infinity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t area under the plasma concentration-time curve from time 0 to time t
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax maximum observed plasma concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in CDR-SB Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: AUC0-112 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Ejection fraction (EF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Comparative density of sleeves
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Utility-Weighted Modified Rankin Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in food insecurity category
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in nutritional security score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Craniotomy bone flap healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Ultrasound diaphragmatic function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of concordance between VI-RADS score and pathologic muscularis propria invasion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: BOLD-response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes